Christopher Black/The Canadian Press
Thursday, June 14, 2012 – Globe and Mail
ANNA MEHLER PAPERNY
A team of Canadian researchers has developed one of the most effective cures yet for the Ebola virus. That’s big news both for treating the deadliest virus on Earth and tackling myriad other similarly aggressive diseases.
The treatment, in which injections of protein-grabbing antibodies stop a virus from replicating, has the longest treatment window so far resulting in full recovery – a full day. There’s just one catch: It can take up to two weeks for symptoms of the disease to appear.
Gary Kobinger has been chasing vaccines since childhood.
Growing up in Quebec City in the early 1990s, he remembers being galvanized to action by documentaries about people infected with HIV-AIDS – back when the illness was still new, mysterious and terrifying.
“In my mind, as a teenager, this was unacceptable. So I decided this was where I would put my energy.”
Photo by Henry Romero/Reuters
April 3, 2012 – Globe and Mail
ANNA MEHLER PAPERNY
There are still serious shortcomings in the way public-health bodies communicate with physicians, nurses and pharmacists on the front lines of a pandemic, says the Public Health Agency of Canada.
And almost three years after a flu pandemic put the country on high alert, the federal agency has put out a call for a new strategy to improve communication with clinicians during pandemic response.
Monday, November 2, 2009 – Globe and Mail
KAREN HOWLETT, ANNA MEHLER PAPERNY AND DAWN WALTON
TORONTO and CALGARY — Patients at private medical clinics in at least two provinces have jumped the queue for H1N1 vaccine during a nationwide shortage of the flu shot, rekindling a debate about the perils of two-tier health care in Canada.
Copeman Healthcare, a private clinic in Vancouver that charges patients annual membership fees of $3,900 in the first year, has already received its first shipment of H1N1 vaccine and is hoping for more soon, said chief operating officer Chris Nedelmann.
Medcan, a clinic in downtown Toronto that charges just under $2,000 for a head-to-toe checkup, received 3,000 doses last Friday, enough for 8 per cent of its patients.